Cy5.5 NHS Ester (Non-Sulfonated): Revolutionizing Near-Infrared Fluorescent Labeling for Biomolecule Imaging

Principle & Setup: The Science Behind Cy5.5 NHS Ester (Non-Sulfonated)

The Cy5.5 NHS ester (non-sulfonated) is a near-infrared fluorescent dye for biomolecule labeling, specifically engineered to meet the demands of contemporary molecular imaging. Operating through NHS ester chemistry, this reagent targets primary amines on peptides, proteins, and oligonucleotides, forming stable amide bonds. With excitation/emission maxima at 684/710 nm, Cy5.5 NHS ester minimizes background autofluorescence, enabling exceptional signal-to-noise ratios in deep tissue and in vivo fluorescence imaging.

Unlike many sulfonated analogs, the non-sulfonated form offers enhanced membrane permeability and lower aqueous solubility—attributes that can be leveraged for specific labeling strategies in both cell-based and animal models. Its solubility of >35.82 mg/mL in DMSO and compatibility with DMF ensures it integrates seamlessly with diverse biomolecule conjugation protocols.

APExBIO, as the trusted supplier, ensures that each batch of Cy5.5 NHS ester meets rigorous stability and purity standards, with the solid form retaining stability for 24 months at -20°C when protected from light.

Step-by-Step Workflow: Protocol Enhancements for Protein & Oligonucleotide Labeling

1. Preparation & Solubilization

• Storage: Store the dye as a solid at -20°C in the dark. Minimize freeze-thaw cycles.
• Solubilization: Immediately before use, dissolve Cy5.5 NHS ester (non-sulfonated) in anhydrous DMSO or DMF to a working stock (e.g., 10 mM). Avoid aqueous solvents at this stage due to rapid hydrolysis of the NHS ester.

2. Buffer Selection & Biomolecule Preparation

• Buffer the target biomolecule (protein, peptide, or oligonucleotide) in a non-amine containing buffer such as PBS (pH 7.2–7.5) or sodium bicarbonate (pH 8.3). Tris or other primary amine buffers will quench labeling efficiency.
• Remove excess amines and small molecules via desalting columns or dialysis prior to conjugation.

3. Labeling Reaction

• Combine biomolecule (typically 1–10 mg/mL) with Cy5.5 NHS ester at a 5–10 molar excess (higher ratios may be required for low-amine targets).
• Incubate at room temperature for 30–60 minutes, protected from light.
• For nucleic acids, ensure the presence of primary amine modifications (e.g., 5'-amino linkers).

4. Purification & Validation

• Separate labeled biomolecule from free dye using size-exclusion chromatography, spin columns, or HPLC.
• Quantify labeling efficiency by measuring absorbance at 684 nm (Cy5.5) and the biomolecule’s native absorbance (e.g., 280 nm for proteins).

5. Storage & Handling

• Store conjugates at 4°C, protected from light. For long-term storage, aliquot and freeze at -20°C.

For a hands-on, scenario-based protocol analysis, see Optimizing Cell Assays with Cy5.5 NHS Ester (Non-Sulfonated), which complements this workflow by focusing on maximizing reproducibility and sensitivity in cellular imaging contexts.

Advanced Applications: From Tumor Imaging to Microbiome Targeting

The unique performance envelope of Cy5.5 NHS ester (non-sulfonated) positions it as a premier fluorescent dye for protein conjugation and a potent tumor imaging agent in preclinical research.

• Optical Imaging of Tumors: Leveraging its near-infrared properties, Cy5.5-labeled antibodies or peptides demonstrate robust tumor delineation and deep tissue penetration in live small animal models. In a recent Science Advances study, near-infrared labeled probes were instrumental in tracking the in vivo distribution and pharmacokinetics of nanovaccines, underscoring the utility of NIR dyes like Cy5.5 NHS ester for real-time tumor monitoring.
• Microbiome and Metastasis Research: The reference study also highlights the emerging use of NIR fluorescent labeling for visualizing bacteria within tumors, enabling researchers to interrogate the interplay between the tumor microenvironment and its associated microbiota—a field where traditional antibiotics fall short. This expands the role of Cy5.5 NHS ester in both in vivo fluorescence imaging and the study of tumor-microbiome dynamics.
• Molecular Biology and Biosensor Development: Cy5.5 NHS ester is increasingly used in FRET assays, biosensors, and as a tracking agent for labeled nucleic acids, enabling quantitation and localization at the single-cell and tissue level.

For a comparative look at performance in neuromodulation and next-generation imaging, Cy5.5 NHS Ester (Non-Sulfonated): NIR Fluorophore for Next-Gen Imaging extends the discussion to emerging fields, contrasting with the tumor-centric focus here.

Additional insights into mechanism, protocol optimization, and biological rationale are detailed in Cy5.5 NHS Ester (Non-Sulfonated): Near-Infrared Dye for Biomolecule Labeling, which complements this guide by providing a comprehensive technical overview.

Troubleshooting & Optimization: Maximizing Labeling Efficiency and Imaging Clarity

Common Pitfalls & Solutions

• Low Labeling Efficiency: Most often traced to NHS hydrolysis. Always prepare dye stocks fresh, add to reaction rapidly, and avoid aqueous pre-dissolution.
• High Background or Aggregation: Excess free dye can cause nonspecific signals. Rigorous purification using size-exclusion techniques is essential. Using the minimal effective dye:protein ratio reduces background.
• Buffer Interference: Tris and glycine buffers compete with target amines. Use phosphate or bicarbonate buffers for all labeling steps.
• Signal Loss or Photobleaching: Protect all steps from ambient light, and minimize exposure during imaging. Store conjugates in the dark.
• Inconsistent Results: Standardize biomolecule concentration, pH, and reaction temperature across experiments. Batch-to-batch consistency is enhanced by sourcing Cy5.5 NHS ester from a reliable vendor like APExBIO.

Protocol Enhancements

• For cell surface labeling, optimize reaction time and temperature to balance labeling efficiency and cell viability.
• In in vivo tumor imaging, validate probe specificity by including non-targeted controls and performing serial time-point imaging to assess pharmacokinetics.
• For nucleic acid labeling, ensure complete removal of unreacted dye by multiple desalting steps to prevent fluorescence quenching.

For more troubleshooting insight, consult Enhancing Assay Reliability with Cy5.5 NHS Ester (Non-Sulfonated), which extends this section with scenario-based solutions for cell viability and cytotoxicity assays.

Future Outlook: Expanding the Horizons of Near-Infrared Fluorescence Imaging

Recent advances, including the Science Advances polyvalent vaccine study, highlight the expanding role of near-infrared fluorophores like Cy5.5 NHS ester in unraveling complex disease biology. As multiplexed imaging, single-cell analytics, and spatial transcriptomics become routine, the demand for high-performance, deeply penetrating, and highly specific fluorescent labels will only increase.

Emerging applications include:

• Multiplexed in vivo imaging: Using dyes with distinct excitation/emission profiles (e.g., Cy5.5, Cy7) for simultaneous tracking of multiple targets.
• Precision biomarker quantification: Leveraging the low background and high quantum yield of Cy5.5 NHS ester for high-dynamic-range detection in biosensors.
• Theranostics: Combining labeled antibodies or peptides for both targeted imaging and drug delivery.

With its robust NHS-amine chemistry, NIR spectral properties, and proven utility in diverse experimental paradigms, Cy5.5 NHS ester (non-sulfonated) is poised to remain a linchpin in the next generation of fluorescent labeling in molecular biology and tumor imaging agent development. Sourcing from APExBIO ensures consistent results, technical support, and access to the latest innovations in dye chemistry.

Conclusion

The Cy5.5 NHS ester (non-sulfonated) stands out as a best-in-class amino group labeling reagent and fluorescent dye for protein conjugation, offering researchers an unrivaled combination of sensitivity, specificity, and flexibility for advanced molecular and in vivo imaging. By following optimized workflows, leveraging troubleshooting insights, and staying abreast of evolving applications, laboratories can maximize the impact of this high-performance reagent in both basic and translational research.